Search research articles
Contact Us
Filters
Showing results (201-210 of 228) with videos related to
Page
of 23
Sort By:
International Journal of Cancer
|
July 29, 2011
Identification of a novel recurrent 1q42.2-1qter deletion in high risk MYCN single copy 11q deleted neuroblastomas
Annelies Fieuw, Candy Kumps, Alexander Schramm, et al.
Cancers
|
February 9, 2020
Plasma Next Generation Sequencing and Droplet Digital-qPCR-Based Quantification of Circulating Cell-Free RNA for Noninvasive Early Detection of Cancer
Martin Metzenmacher, Renáta Váraljai, Balazs Hegedüs, et al.
Nature Medicine
|
April 30, 2024
Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial
Martin Schuler, Kristof Cuppens, Till Plönes, et al.
Molecular Cell
|
December 15, 2010
The miR-17-92 microRNA cluster regulates multiple components of the TGF-β pathway in neuroblastoma
Pieter Mestdagh, Anna-Karin Boström, Francis Impens, et al.
Communications Biology
|
July 30, 2024
A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma
Tatsiana Ryl, Elena Afanasyeva, Till Hartmann, et al.
BMJ Open
|
March 27, 2025
NeoTRACK trial: <u>Neo</u>adjuvant <u>T</u>i<u>R</u>agolumab, <u>A</u>tezolizumab and <u>C</u>hemotherapy - dissection of IO- efficacy in NSCLC by longitudinal trac<u>K</u>ing - protocol of a non-randomised, open-label, single-arm, phase II study
Romina M Roesch, Johannes Schnorbach, Laura V Klotz, et al.
Cell Reports
|
November 24, 2021
Statins affect cancer cell plasticity with distinct consequences for tumor progression and metastasis
Madeleine Dorsch, Manuela Kowalczyk, Mélanie Planque, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2010
Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature
Katleen De Preter, Joëlle Vermeulen, Benedikt Brors, et al.
Oncotarget
|
March 2, 2018
The mutational landscape of <i>MYCN</i>, <i>Lin28b</i> and <i>ALK</i><sup></sup> driven murine neuroblastoma mimics human disease
Bram De Wilde, Anneleen Beckers, Sven Lindner, et al.
Plos One
|
January 12, 2013
Focal DNA copy number changes in neuroblastoma target MYCN regulated genes
Candy Kumps, Annelies Fieuw, Pieter Mestdagh, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 228) with videos related to
Sort By:
Page
of 23
International Journal of Cancer
|
July 29, 2011
Identification of a novel recurrent 1q42.2-1qter deletion in high risk MYCN single copy 11q deleted neuroblastomas
Annelies Fieuw, Candy Kumps, Alexander Schramm, et al.
Cancers
|
February 9, 2020
Plasma Next Generation Sequencing and Droplet Digital-qPCR-Based Quantification of Circulating Cell-Free RNA for Noninvasive Early Detection of Cancer
Martin Metzenmacher, Renáta Váraljai, Balazs Hegedüs, et al.
Nature Medicine
|
April 30, 2024
Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial
Martin Schuler, Kristof Cuppens, Till Plönes, et al.
Molecular Cell
|
December 15, 2010
The miR-17-92 microRNA cluster regulates multiple components of the TGF-β pathway in neuroblastoma
Pieter Mestdagh, Anna-Karin Boström, Francis Impens, et al.
Communications Biology
|
July 30, 2024
A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma
Tatsiana Ryl, Elena Afanasyeva, Till Hartmann, et al.
BMJ Open
|
March 27, 2025
NeoTRACK trial: <u>Neo</u>adjuvant <u>T</u>i<u>R</u>agolumab, <u>A</u>tezolizumab and <u>C</u>hemotherapy - dissection of IO- efficacy in NSCLC by longitudinal trac<u>K</u>ing - protocol of a non-randomised, open-label, single-arm, phase II study
Romina M Roesch, Johannes Schnorbach, Laura V Klotz, et al.
Cell Reports
|
November 24, 2021
Statins affect cancer cell plasticity with distinct consequences for tumor progression and metastasis
Madeleine Dorsch, Manuela Kowalczyk, Mélanie Planque, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2010
Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature
Katleen De Preter, Joëlle Vermeulen, Benedikt Brors, et al.
Oncotarget
|
March 2, 2018
The mutational landscape of <i>MYCN</i>, <i>Lin28b</i> and <i>ALK</i><sup></sup> driven murine neuroblastoma mimics human disease
Bram De Wilde, Anneleen Beckers, Sven Lindner, et al.
Plos One
|
January 12, 2013
Focal DNA copy number changes in neuroblastoma target MYCN regulated genes
Candy Kumps, Annelies Fieuw, Pieter Mestdagh, et al.
Page
of 23